Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adil Al-Nahhas

Showing results (81-90 of 124) with videos related to

Pageof 13
Sort By:
Annals of Nuclear Medicine|June 15, 2010
Role of 11C-choline PET/CT in the restaging of prostate cancer patients showing a single lesion on bone scintigraphyChiara Fuccio, Paolo Castellucci, Riccardo Schiavina, et al.
Nuclear Medicine Communications|November 20, 2010
Increased serum thyroglobulin levels and negative imaging in thyroid cancer patients: are there sources of benign secretion? A speculative short reviewPaolo Zanotti-Fregonara, Isabelle Keller, Marie Calzada-Nocaudie, et al.
Nuclear Medicine Communications|April 27, 2007
Role of 18F-dopa PET/CT imaging in the management of patients with 111In-pentetreotide negative GEP tumoursValentina Ambrosini, Paola Tomassetti, Domenico Rubello, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 17, 2013
18F-ICMT-11, a caspase-3-specific PET tracer for apoptosis: biodistribution and radiation dosimetryAmarnath Challapalli, Laura M Kenny, William A Hallett, et al.
European Journal of Radiology|August 7, 2010
FDG-PET/CT in advanced ovarian cancer staging: value and pitfalls in detecting lesions in different abdominal and pelvic quadrants compared with laparoscopyPierandrea De Iaco, Alessandra Musto, Luca Orazi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 5, 2010
Reproducibility of [11C]choline-positron emission tomography and effect of trastuzumabLaura M Kenny, Kaiyumars B Contractor, Rainer Hinz, et al.
Nuclear Medicine Communications|April 4, 2014
The value of combined assessment of vertebral fractures with 99mTc MDP scintigraphy and MRI in selecting and planning percutaneous vertebroplastyDerfel ap Dafydd, Shahenda Salem, Imene Zerizer, et al.
Nuclear Medicine Communications|November 9, 2013
Exploring the potential of [11C]choline-PET/CT as a novel imaging biomarker for predicting early treatment response in prostate cancerAmarnath Challapalli, Tara Barwick, Giampaolo Tomasi, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|September 24, 2015
Role of Staging in Patients with Small Intestinal Neuroendocrine TumoursAshley Kieran Clift, Omar Faiz, Adil Al-Nahhas, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 3, 2006
Deep-seated resistance in relapsed paratyphoid feverGraham S Cooke, Fiona J Cooke, Madeline Stone, et al.
Pageof 13

Showing results (81-90 of 124) with videos related to

Sort By:
Pageof 13
Annals of Nuclear Medicine|June 15, 2010
Role of 11C-choline PET/CT in the restaging of prostate cancer patients showing a single lesion on bone scintigraphyChiara Fuccio, Paolo Castellucci, Riccardo Schiavina, et al.
Nuclear Medicine Communications|November 20, 2010
Increased serum thyroglobulin levels and negative imaging in thyroid cancer patients: are there sources of benign secretion? A speculative short reviewPaolo Zanotti-Fregonara, Isabelle Keller, Marie Calzada-Nocaudie, et al.
Nuclear Medicine Communications|April 27, 2007
Role of 18F-dopa PET/CT imaging in the management of patients with 111In-pentetreotide negative GEP tumoursValentina Ambrosini, Paola Tomassetti, Domenico Rubello, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 17, 2013
18F-ICMT-11, a caspase-3-specific PET tracer for apoptosis: biodistribution and radiation dosimetryAmarnath Challapalli, Laura M Kenny, William A Hallett, et al.
European Journal of Radiology|August 7, 2010
FDG-PET/CT in advanced ovarian cancer staging: value and pitfalls in detecting lesions in different abdominal and pelvic quadrants compared with laparoscopyPierandrea De Iaco, Alessandra Musto, Luca Orazi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 5, 2010
Reproducibility of [11C]choline-positron emission tomography and effect of trastuzumabLaura M Kenny, Kaiyumars B Contractor, Rainer Hinz, et al.
Nuclear Medicine Communications|April 4, 2014
The value of combined assessment of vertebral fractures with 99mTc MDP scintigraphy and MRI in selecting and planning percutaneous vertebroplastyDerfel ap Dafydd, Shahenda Salem, Imene Zerizer, et al.
Nuclear Medicine Communications|November 9, 2013
Exploring the potential of [11C]choline-PET/CT as a novel imaging biomarker for predicting early treatment response in prostate cancerAmarnath Challapalli, Tara Barwick, Giampaolo Tomasi, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|September 24, 2015
Role of Staging in Patients with Small Intestinal Neuroendocrine TumoursAshley Kieran Clift, Omar Faiz, Adil Al-Nahhas, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 3, 2006
Deep-seated resistance in relapsed paratyphoid feverGraham S Cooke, Fiona J Cooke, Madeline Stone, et al.
Pageof 13